The emergence of top-down proteomics in clinical research

Genome Medicine

Volumn 5, Issue 6, 2013, Pages

  Savaryn, John P ^a   Catherman, Adam D ^a   Thomas, Paul M ^a   Abecassis, Michael M ^b   Kelleher, Neil L ^a,c  

^a Chemistry of Life Processes Institute   (United States)

^b Tarry Bldg   (United States)

^c NORTHWESTERN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PEPTIDE;

ARTICLE; CLINICAL RESEARCH; ELECTROSPRAY MASS SPECTROMETRY; FLOW CYTOMETRY; MASS SPECTROMETRY; PHENOTYPE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEOMICS; SURFACE ENHANCED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; LIQUID CHROMATOGRAPHY; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; PROTEIN BLOOD LEVEL; PROTEIN PHOSPHORYLATION; PROTEIN TARGETING; SENSITIVITY ANALYSIS; TWO DIMENSIONAL GEL ELECTROPHORESIS;

EID: 84879075349     PISSN: None     EISSN: 1756994X     Source Type: Journal    
DOI: 10.1186/gm457     Document Type: Article

References (41)

1. Chen R, Snyder M. Promise of personalized omics to precision medicine. Wiley Interdiscip Rev Syst Biol Med 2013, 5:73-82. 10.1002/wsbm.1198, 23184638.
2. Mann M. Proteomics for biomedicine: a half-completed journey. EMBO Mol Med 2012, 4:75-77. 10.1002/emmm.201100198, 3376839, 22278912.
3. Bystrom CE, Salameh W, Reitz R, Clarke NJ. Plasma renin activity by LC-MS/MS: development of a prototypical clinical assay reveals a subpopulation of human plasma samples with substantial peptidase activity. Clin Chem 2010, 56:1561-1569. 10.1373/clinchem.2010.146449, 20739638.
4. Boersema PJ, Geiger T, Wisniewski JR, Mann M. Quantification of the N-glycosylated secretome by super-SILAC during breast cancer progression and in human blood samples. Mol Cell Proteomics 2013, 12:158-171. 10.1074/mcp.M112.023614, 3536897, 23090970.
5. Wisniewski JR, Dus K, Mann M. Proteomic workflow for analysis of archival formalin-fixed and paraffin-embedded clinical samples to a depth of 10 000 proteins. Proteomics Clin Appl 2013, 7:225-233. 10.1002/prca.201200046, 23090905.
6. Zanivan S, Meves A, Behrendt K, Schoof EM, Neilson LJ, Cox J, Tang HR, Kalna G, van Ree JH, van Deursen JM, Trempus CS, Machesky LM, Linding R, Wickström SA, Fässler R, Mann M. In vivo SILAC-based proteomics reveals phosphoproteome changes during mouse skin carcinogenesis. Cell Rep 2013, 3:552-566. 10.1016/j.celrep.2013.01.003, 23375375.
7. Dendrou CA, Bell JI, Fugger L. Weighing in on autoimmune disease: big data tip the scale. Nat Med 2013, 19:138-139. 10.1038/nm.3087, 23389608.
8. Anderson L, Hunter CL. Quantitative mass spectrometric multiple reaction monitoring assays for major plasma proteins. Mol Cell Proteomics 2006, 5:573-588.
9. Kelleher NL. Spinning up mass spectrometry for whole protein complexes. Nat Methods 2012, 9:1065-1066. 10.1038/nmeth.2216, 23132117.
10. Anderson NL, Anderson NG. The human plasma proteome: history, character, and diagnostic prospects. Mol Cell Proteomics 2002, 1:845-867. 10.1074/mcp.R200007-MCP200, 12488461.
11. Whiteaker JR, Zhao L, Zhang HY, Feng LC, Piening BD, Anderson L, Paulovich AG. Antibody-based enrichment of peptides on magnetic beads for mass-spectrometry-based quantification of serum biomarkers. Anal Biochem 2007, 362:44-54. 10.1016/j.ab.2006.12.023, 1852426, 17241609.
12. Huillet C, Adrait A, Lebert D, Picard G, Trauchessec M, Louwagie M, Dupuis A, Hittinger L, Ghaleh B, Le Corvoisier P, Jaquinod M, Garin J, Bruley C, Brun V. Accurate quantification of cardiovascular biomarkers in serum using Protein Standard Absolute Quantification (PSAQ) and selected reaction monitoring. Mol Cell Proteomics 2012, 11:M111.008235. 10.1074/mcp.M111.008235, 3277748, 22080464.
13. Keshishian H, Addona T, Burgess M, Kuhn E, Carr SA. Quantitative, multiplexed assays for low abundance proteins in plasma by targeted mass spectrometry and stable isotope dilution. Mol Cell Proteomics 2007, 6:2212-2229. 10.1074/mcp.M700354-MCP200, 2435059, 17939991.
14. Apple FS. A new season for cardiac troponin assays: it's time to keep a scorecard. Clin Chem 2009, 55:1303-1306. 10.1373/clinchem.2009.128363, 19478023.
15. Lepor H, Cheli CD, Thiel RP, Taneja SS, Laze J, Chan DW, Sokoll LJ, Mangold L, Partin AW. Clinical evaluation of a novel method for the measurement of prostate-specific antigen, AccuPSA™, as a predictor of 5-year biochemical recurrence-free survival after radical prostatectomy: results of a pilot study. BJU Int 2012, 109:1770-1775. 10.1111/j.1464-410X.2011.10568.x, 21992499.
16. Carr SA, Anderson L. Protein quantitation through targeted mass spectrometry: the way out of biomarker purgatory?. Clinical Chem 2008, 54:1749-1752.
17. Jia Y, Wu T, Jelinek CA, Bielekova B, Chang L, Newsome S, Gnanapavan S, Giovannoni G, Chen D, Calabresi PA, Nath A, Cotter RJ. Development of protein biomarkers in cerebrospinal fluid for secondary progressive multiple sclerosis using selected reaction monitoring mass spectrometry (SRM-MS). Clin Proteomics 2012, 9:9. 3466133, 22846148.
18. Huttenhain R, Soste M, Selevsek N, Rost H, Sethi A, Carapito C, Farrah T, Deutsch EW, Kusebauch U, Moritz RL, Nimeus-Malmstrom E, Rinner O, Aebersold R. Reproducible quantification of cancer-associated proteins in body fluids using targeted proteomics. Sci Transl Med 2012, 4:142ra194.
19. Musselman CA, Lalonde ME, Côté J, Kutateladze TG. Perceiving the epigenetic landscape through histone readers. Nat Struct Mol Biol 2012, 19:1218-1227. 10.1038/nsmb.2436, 3645987, 23211769.
20. Smith LM, Kelleher NL, Consortium for Top Down Proteomics Proteoform: a single term describing protein complexity. Nat Methods 2013, 10:186-187. 10.1038/nmeth.2369, 23443629, Consortium for Top Down Proteomics.
21. O'Farrell PH. High resolution two-dimensional electrophoresis of proteins. J Biol Chem 1975, 250:4007-4021. 2874754, 236308.
22. Unlu M, Morgan ME, Minden JS. Difference gel electrophoresis: a single gel method for detecting changes in protein extracts. Electrophoresis 1997, 18:2071-2077. 10.1002/elps.1150181133, 9420172.
23. Bloom GC, Eschrich S, Zhou JX, Coppola D, Yeatman TJ. Elucidation of a protein signature discriminating six common types of adenocarcinoma. Int J Cancer 2007, 120:769-775. 10.1002/ijc.22041, 17131332.
24. Zhou G, Li H, DeCamp D, Chen S, Shu H, Gong Y, Flaig M, Gillespie JW, Hu N, Taylor PR, Emmert-Buck MR, Liotta LA, Petricoin EF, Zhao Y. 2D Differential in-gel electrophoresis for the identification of esophageal scans cell cancer-specific protein markers. Mol Cell Proteomics 2002, 1:117-124. 10.1074/mcp.M100015-MCP200, 12096129.
25. Gygi SP, Corthals GL, Zhang Y, Rochon Y, Aebersold R. Evaluation of two-dimensional gel electrophoresis-based proteome analysis technology. Proc Natl Acad Sci USA 2000, 97:9390-9395. 10.1073/pnas.160270797, 16874, 10920198.
26. Ong SE, Pandey A. An evaluation of the use of two-dimensional gel electrophoresis in proteomics. Biomol Eng 2001, 18:195-205. 10.1016/S1389-0344(01)00095-8, 11911086.
27. Kellie JF, Catherman AD, Durbin KR, Tran JC, Tipton JD, Norris JL, Witkowski CE, Thomas PM, Kelleher NL. Robust analysis of the yeast proteome under 50 kDa by molecular-mass-based fractionation and top-down mass spectrometry. Anal Chem 2012, 84:209-215. 10.1021/ac202384v, 3262231, 22103811.
28. Tran JC, Zamdborg L, Ahlf DR, Lee JE, Catherman AD, Durbin KR, Tipton JD, Vellaichamy A, Kellie JF, Li M, Wu C, Sweet SM, Early BP, Siuti N, LeDuc RD, Compton PD, Thomas PM, Kelleher NL. Mapping intact protein isoforms in discovery mode using top-down proteomics. Nature 2011, 480:254-258. 10.1038/nature10575, 3237778, 22037311.
29. Auffray C, Caulfield T, Khoury MJ, Lupski JR, Schwab M, Veenstra T. 2012 Highlights in translational 'omics. Genome Med 2013, 5:10.
30. Wu C, Tran JC, Zamdborg L, Durbin KR, Li M, Ahlf DR, Early BP, Thomas PM, Sweedler JV, Kelleher NL. A protease for 'middle-down' proteomics. Nat Methods 2012, 9:822-824. 10.1038/nmeth.2074, 3430368, 22706673.
31. Petricoin E, Liotta LA. The vision for a new diagnostic paradigm. Clin Chem 2003, 49:1276-1278. 10.1373/49.8.1276, 12881442.
32. Oppenheimer SR, Mi D, Sanders ME, Caprioli RM. Molecular analysis of tumor margins by MALDI mass spectrometry in renal carcinoma. J Proteome Res 2010, 9:2182-2190. 10.1021/pr900936z, 2866033, 20141219.
33. Chamot-Rooke J, Mikaty G, Malosse C, Soyer M, Dumont A, Gault J, Imhaus AF, Martin P, Trellet M, Clary G, Chafey P, Camoin L, Nilges M, Nassif X, Dumenil G. Posttranslational modification of pili upon cell contact triggers N. meningitidis dissemination. Science 2011, 331:778-782. 10.1126/science.1200729, 21311024.
34. Dong X, Sumandea CA, Chen YC, Garcia-Cazarin ML, Zhang J, Balke CW, Sumandea MP, Ge Y. Augmented phosphorylation of cardiac troponin I in hypertensive heart failure. J Biol Chem 2012, 287:848-857. 10.1074/jbc.M111.293258, 3256890, 22052912.
35. Mazur MT, Cardasis HL, Spellman DS, Liaw A, Yates NA, Hendrickson RC. Quantitative analysis of intact apolipoproteins in human HDL by top-down differential mass spectrometry. Proc Natl Acad Sci USA 2010, 107:7728-7733. 10.1073/pnas.0910776107, 2867874, 20388904.
36. Molnar KS, Karabacak NM, Johnson JL, Wang Q, Tiwari A, Hayward LJ, Coales SJ, Hamuro Y, Agar JN. A common property of amyotrophic lateral sclerosis-associated variants: destabilization of the copper/zinc superoxide dismutase electrostatic loop. J Biol Chem 2009, 284:30965-30973. 10.1074/jbc.M109.023945, 2781497, 19635794.
37. Ahlf DR, Compton PD, Tran JC, Early BP, Thomas PM, Kelleher NL. Evaluation of the compact high-field orbitrap for top-down proteomics of human cells. J Proteome Res 2012, 11:4308-4314. 10.1021/pr3004216, 22746247.
38. Tian Z, Tolić N, Zhao R, Moore RJ, Hengel SM, Robinson EW, Stenoien DL, Wu S, Smith RD, Paša-Tolić L. Enhanced top-down characterization of histone post-translational modifications. Genome Biol 2012, 13:R86. 10.1186/gb-2012-13-10-r86, 3491414, 23034525.
39. Consortium for Top Down Proteomics. , http://www.topdownproteomics.org
40. Bendall SC, Simonds EF, Qiu P, Amir ED, Krutzik PO, Finck R, Bruggner RV, Melamed R, Trejo A, Ornatsky OI, Balderas RS, Plevritis SK, Sachs K, Pe'er D, Tanner SD, Nolan GP. Single-cell mass cytometry of differential immune and drug responses across a human hematopoietic continuum. Science 2011, 332:687-696. 10.1126/science.1198704, 3273988, 21551058.
41. Borges CR, Oran PE, Buddi S, Jarvis JW, Schaab MR, Rehder DS, Rogers SP, Taylor T, Nelson RW. Building multidimensional biomarker views of type 2 diabetes on the basis of protein microheterogeneity. Clin Chem 2011, 57:719-728. 10.1373/clinchem.2010.156976, 21402800.